Zhengye Biotechnology Holding (ZYBT) Accumulated Depreciation & Amortization (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $14.2 million as the latest value for Q4 2024.
- Quarterly Accumulated Depreciation & Amortization rose 20.07% to $14.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $14.2 million through Dec 2024, up 20.07% year-over-year, with the annual reading at $14.2 million for FY2024, 17.81% up from the prior year.
- Accumulated Depreciation & Amortization for Q4 2024 was $14.2 million at Zhengye Biotechnology Holding, up from $11.8 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $14.2 million in Q4 2024, with the low at $11.8 million in Q4 2023.